Cargando…

Application of reverse-phase HPLC to quantify oligopeptide acetylation eliminates interference from unspecific acetyl CoA hydrolysis

Protein acetylation is a common modification that plays a central role in several cellular processes. The most widely used methods to study these modifications are either based on the detection of radioactively acetylated oligopetide products or an enzyme-coupled reaction measuring conversion of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Evjenth, Rune, Hole, Kristine, Ziegler, Mathias, Lillehaug, Johan R
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2722098/
https://www.ncbi.nlm.nih.gov/pubmed/19660098
http://dx.doi.org/10.1186/1753-6561-3-S6-S5
_version_ 1782170287276556288
author Evjenth, Rune
Hole, Kristine
Ziegler, Mathias
Lillehaug, Johan R
author_facet Evjenth, Rune
Hole, Kristine
Ziegler, Mathias
Lillehaug, Johan R
author_sort Evjenth, Rune
collection PubMed
description Protein acetylation is a common modification that plays a central role in several cellular processes. The most widely used methods to study these modifications are either based on the detection of radioactively acetylated oligopetide products or an enzyme-coupled reaction measuring conversion of the acetyl donor acetyl CoA to the product CoASH. Due to several disadvantages of these methods, we designed a new method to study oligopeptide acetylation. Based on reverse phase HPLC we detect both reaction products in a highly robust and reproducible way. The method reported here is also fully compatible with subsequent product analysis, e.g. by mass spectroscopy. The catalytic subunit, hNaa30p, of the human NatC protein N-acetyltransferase complex was used for N-terminal oligopeptide acetylation. We show that unacetylated and acetylated oligopeptides can be efficiently separated and quantified by the HPLC-based analysis. The method is highly reproducible and enables reliable quantification of both substrates and products. It is therefore well-suited to determine kinetic parameters of acetyltransferases.
format Text
id pubmed-2722098
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27220982009-08-06 Application of reverse-phase HPLC to quantify oligopeptide acetylation eliminates interference from unspecific acetyl CoA hydrolysis Evjenth, Rune Hole, Kristine Ziegler, Mathias Lillehaug, Johan R BMC Proc Proceedings Protein acetylation is a common modification that plays a central role in several cellular processes. The most widely used methods to study these modifications are either based on the detection of radioactively acetylated oligopetide products or an enzyme-coupled reaction measuring conversion of the acetyl donor acetyl CoA to the product CoASH. Due to several disadvantages of these methods, we designed a new method to study oligopeptide acetylation. Based on reverse phase HPLC we detect both reaction products in a highly robust and reproducible way. The method reported here is also fully compatible with subsequent product analysis, e.g. by mass spectroscopy. The catalytic subunit, hNaa30p, of the human NatC protein N-acetyltransferase complex was used for N-terminal oligopeptide acetylation. We show that unacetylated and acetylated oligopeptides can be efficiently separated and quantified by the HPLC-based analysis. The method is highly reproducible and enables reliable quantification of both substrates and products. It is therefore well-suited to determine kinetic parameters of acetyltransferases. BioMed Central 2009-08-04 /pmc/articles/PMC2722098/ /pubmed/19660098 http://dx.doi.org/10.1186/1753-6561-3-S6-S5 Text en Copyright © 2009 Evjenth et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Proceedings
Evjenth, Rune
Hole, Kristine
Ziegler, Mathias
Lillehaug, Johan R
Application of reverse-phase HPLC to quantify oligopeptide acetylation eliminates interference from unspecific acetyl CoA hydrolysis
title Application of reverse-phase HPLC to quantify oligopeptide acetylation eliminates interference from unspecific acetyl CoA hydrolysis
title_full Application of reverse-phase HPLC to quantify oligopeptide acetylation eliminates interference from unspecific acetyl CoA hydrolysis
title_fullStr Application of reverse-phase HPLC to quantify oligopeptide acetylation eliminates interference from unspecific acetyl CoA hydrolysis
title_full_unstemmed Application of reverse-phase HPLC to quantify oligopeptide acetylation eliminates interference from unspecific acetyl CoA hydrolysis
title_short Application of reverse-phase HPLC to quantify oligopeptide acetylation eliminates interference from unspecific acetyl CoA hydrolysis
title_sort application of reverse-phase hplc to quantify oligopeptide acetylation eliminates interference from unspecific acetyl coa hydrolysis
topic Proceedings
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2722098/
https://www.ncbi.nlm.nih.gov/pubmed/19660098
http://dx.doi.org/10.1186/1753-6561-3-S6-S5
work_keys_str_mv AT evjenthrune applicationofreversephasehplctoquantifyoligopeptideacetylationeliminatesinterferencefromunspecificacetylcoahydrolysis
AT holekristine applicationofreversephasehplctoquantifyoligopeptideacetylationeliminatesinterferencefromunspecificacetylcoahydrolysis
AT zieglermathias applicationofreversephasehplctoquantifyoligopeptideacetylationeliminatesinterferencefromunspecificacetylcoahydrolysis
AT lillehaugjohanr applicationofreversephasehplctoquantifyoligopeptideacetylationeliminatesinterferencefromunspecificacetylcoahydrolysis